Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia

被引:28
作者
Agaoglu, N [1 ]
Türkyilmaz, S
Ovali, E
Uçar, F
Agaoglu, C
机构
[1] Karadeniz Tech Univ, Dept Gen Surg, Fac Med, TR-61080 Trabzon, Turkey
[2] Karadeniz Tech Univ, Dept Hematol, Fac Med, TR-61080 Trabzon, Turkey
[3] Karadeniz Tech Univ, Fac Med, Dept Med Biol & Genet, TR-61080 Trabzon, Turkey
[4] Golbasi Hosp, Ankara, Turkey
[5] KTU, TR-61080 Trabzon, Turkey
关键词
D O I
10.1007/s00268-005-7692-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Acute mesenteric ischemia (AMI) is a rare condition that may be associated with a variety of congenital prothrombotic disorders (PDs). The purpose of this study was to assess the prevalence of these disorders in 28 AMI patients compared with 103 healthy individuals from the northeastern region of Turkey. They were screened for protein C, antithrombin 111, and protein S deficiencies; and gene analysis was performed using the polymerase chain reaction. A PD was revealed in 16 (57%) patients and 33 (32%) controls (p = 0.020). Factor V Leiden (FVL), prothrombin G20210A mutation, and TT677 homozygous mutation of methylenetetrahydrofolate reductase was detected in 10 (36%) patients versus 16 (15%) controls (p = 0.035), 3 (11%) patients versus 10 (9%) controls (p = 1.00), and 1 (3%) patient versus no controls, respectively. Consistent with caucasian ethnic groups, there was high prevalence of PDs, especially FVL; and these abnormalities might be a significant predisposing factor in the pathogenesis of AMI.
引用
收藏
页码:1135 / 1138
页数:4
相关论文
共 25 条
[1]   Prothrombotic disorders in patients with mesenteric vein thrombosis [J].
Agaoglu, N ;
Türkyilmaz, S .
JOURNAL OF INVESTIGATIVE SURGERY, 2003, 16 (05) :299-304
[2]  
Akar N, 1998, AM J HEMATOL, V58, P249, DOI 10.1002/(SICI)1096-8652(199807)58:3<249::AID-AJH20>3.0.CO
[3]  
2-3
[4]  
Akar N, 1997, THROMB HAEMOSTASIS, V78, P1527
[5]   The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels [J].
Cattaneo, M ;
Chantarangkul, V ;
Taioli, E ;
Santos, JH ;
Tagliabue, L .
THROMBOSIS RESEARCH, 1999, 93 (01) :1-8
[6]   Prevalence of three prothrombotic polymorphisms:: Factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C 677T in Argentina [J].
Genoud, V ;
Castañon, M ;
Annichino-Bizzacchi, J ;
Korin, J ;
Kordich, L .
THROMBOSIS RESEARCH, 2000, 100 (03) :127-131
[7]  
GOMEZ RR, 1997, THROMB HAEMOSTASIS, V77, P224
[8]   Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis [J].
Gurgey, A ;
Haznedaroglu, IC ;
Egesel, T ;
Buyukasik, Y ;
Ozcebe, OI ;
Sayinalp, N ;
Dundar, SV ;
Bayraktar, Y .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 67 (02) :107-111
[9]   Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations [J].
Jacques, PF ;
Bostom, AG ;
Williams, RR ;
Ellison, RC ;
Eckfeldt, JH ;
Rosenberg, IH ;
Selhub, J ;
Rozen, R .
CIRCULATION, 1996, 93 (01) :7-9
[10]   The mutation at position 20210 in the 3′-untranslated region of the prothrombin gene is extremely rare in Taiwanese Chinese patients with venous thrombophilia [J].
Lin, JS ;
Shen, MC ;
Tsay, W .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) :343-343